Objective: This study was conducted to evaluate the indications and outcomes of emergency peripartum hysterectomy (EPH) as a life-saving procedure. Methods: A series of 60 cases of EPH were analyzed, between June 2006 and June 2016. The data were collected from the patients' files. Results: The incidence of EPH was 3 per 1,000 deliveries. The mean age was 34.10 ± 6 years, gravidity was 6.84 ± 3.38 and parity was 5.58 ± 3.0. Of the 60 cases, 40 were delivered by cesarean section and 20 were vaginally delivered. Forty-five cases had subtotal hysterectomy and 15 had total abdominal hysterectomy. The most common indications for EPH were uterine atony followed by uterine rupture and abnormal placentation. Mean operation time was 142.23 ± 43.70 minutes. The average blood transfusion was 4.79 ± 3.36 units. Relaparotomy was performed in 22 cases. Maternal mortality was seen in 10 cases. Conclusion: This study suggests that the most common indications for EPH are uterine atony, uterine rupture and abnormal placentation. This is probably due to the advanced age of pregnancies and multiparity in our region.

No abstract

Urinary tract infections frequently affect pregnant mothers. Three common clinical manifestations of UTIs in pregnancy are: asymptomatic bacteriuria, acute cystitis and acute pyelonephritis. Escherichia coli remain the most frequent organism in UTIs. All pregnant mothers should be screened for UTIs in pregnancy and antibiotics should be commenced without delay. Urine culture and sensitivity is the gold standard in diagnosing UTIs. Asymptomatic bacteriuria in pregnancy is associated with preterm delivery, intrauterine growth retardation, low birth weight, maternal hypertension, pre-eclampsia and anemia. Aims: To know the prevalence of UTI in pregnancy Results: A total of 100 pregnant women were included in the study. 15 patients showed significant bacterial growth making an overall prevalence of 15%. 50%uti is in the age group of 21-25 yrs, 5% of UTI is equally distributed 18 to 20 and 31 to 35 years.

Introduction: Leucorrhoea is an abnormal excessive vaginal discharge often associated with irritation. This is the most common gynaecological problem that brings the women to gynec out patient. The symptom may be associated with cancer phobia. It can be symptom of underlying pelvic pathology. Aims and objective:The aim of the study is analysis of leucorrhoea. This Study was conducted at Dept. of OBG, MVJ medical college and research hospital, Bangalore during the year of 2017. Material and methods:The study consisted of 100 women of age group of15-55 years with complaint of white discharge. The detailed history examination and its association with other symptoms was recorded in ms exel and analyzed statistically. Results: The present study revealed that the disease is prevalent throughout life i.e. 15-55 years, but higher prevalence was observed in mid reproductive period i.e. 25-34 years. Regarding the age distribution analysis 20[20%] cases were between the age of 15-24 years, 50[50%] cases were between the age of 25-34 years, 16[16%] cases were between the age of 35-44 years and 14 [14%] were between the age of 45-54 years, in present study 60% had non specific vaginitis, 17%had trichomonosius, 13% monialisis and 10% had bacterial vaginitis. Conclusion: Leucorrhea is most common gynecological problem of reproductive age group.it can present with local and systemic features. systemic features responds to treatment of white discharge.

Background: Iron deficiency is the most common nutritional deficiency worldwide; it affects 1.6 billion people Iron deficiency (ID) and iron deficiency anemia (IDA) are often encountered in the general population, particularly among children and women with abnormal uterine bleeding (AUB) and during pregnancy as well as postpartum period Intravenous (IV) iron replacement can deliver the total amount of required iron over a short period. Currently, the most commonly used IV iron formulations are iron sucrose (IS) and ferric carboxymaltose (FCM) [4][5][6]. Iron sucrose does not require test dose and is safe. Ferric carboxymaltose (FCM) is the latest I.V. iron formulation which can be used at high doses and allows rapid administration (up to 1000 mg in a single dose infused in 15 minutes) The present study was a comparative study of parenteral iron therapy (intravenous iron sucrose versus intravenous ferric carboxymaltose in the management of iron deficiency anaemia in pregnancy. Methods: In the present study, 50 pregnant women with IDA were randomly distributed into two groups of 25 each. Group -A: 25 receiving intravenous iron sucrose therapy; Group -B: 25 receiving intravenous ferric carboxymaltose therapy. Results: Majority of the study participants in Group A had gestational age between 20-25 weeks (48%). The mean age of the study participants in Group A was found to be 22.86+4.42 weeks. Majority of the study participants in Group B had gestational age between 20-25 weeks (36%). The mean age of the study participants was found to be 23.01+3.01 weeks. Majority of the study participants in Group A had nil parity (40%). 36% of the study participants in Group B had nil parity. 60% of the study participants in group A had Mild degree of anaemia with 52% in group B having mild degree of anaemia. 40% and 44% of the study participants in group A and group B had Moderate degree of anaemia respectively. The association was found to be statistically significant between the mean Hb and Ferritin values pre-treatment, 3rd and 6th week follow-up post treatment and the 2 groups of study participants. The adverse effects were comparatively lower among Group B (IV ferric carboxymaltose) than Group A (IV iron sucrose) of the study participants. Conclusions: IV ferric carboxymaltose administration increases the hemoglobin level more rapidly as compared to iron sucrose in women with iron deficiency anemia in the pregnancy. It also stores iron more rapidly. No serious adverse effects were recorded. Ferric carboxymaltose is well tolerated, safe and effective alternative to iron sucrose in iron deficiency anemia of pregnancy. FCM has the advantage of a large dose administration per sitting and early rise in hemoglobin level.